Rights and permissions
About this article
Cite this article
Golimumab provisionally recommended for RA by NICE. Pharmacoecon. Outcomes News 629, 11 (2011). https://doi.org/10.2165/00151234-201106290-00029
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201106290-00029